Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)
Clinical trial NCT06009861 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06009861
- Sponsor
- Peking University Hospital of Stomatology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-27
- Primary completion
- 2026-06-30
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.